In brief
In a swift response to a World Health Organisation (WHO) report, Tanzania's government has categorically denied the existence of a new suspected outbreak of the Marburg virus in the Kagera region. The WHO had previously indicated that there were nine suspected cases within a five-day period, with reports of eight associated fatalities. Health Minister Jenista Mhagama responded firmly, stating that rigorous analysis of the samples revealed none were positive for the Marburg virus.
This skeptical stance comes in light of Tanzania's earlier experience with the virus, which first appeared in March 2023, resulting in six deaths in Bukoba and lasting nearly two months. The highly infectious nature of the Marburg virus bears similarities to the Ebola virus, manifesting symptoms such as high fever, severe muscle aches, and in dire circumstances, can lead to death from severe blood loss.Despite Tanzania's assertions, WHO Director-General Tedros Adhanom Ghebreyesus forewarned of the potential for additional cases as the country enhances its disease surveillance efforts. The ongoing monitoring includes healthcare workers and individuals exhibiting symptoms. The WHO has noted a heightened risk for virus transmission within Kagera, attributed to its role as a transit point for neighboring countries including Uganda and the Democratic Republic of the Congo.While the organization maintains that there are currently no travel or trade restrictions necessary, it described the global risk stemming from this suspected outbreak as "low." In the wake of these developments, a team of experts was dispatched to Kagera to assist with case identification and containment efforts effectively.Tanzania's health minister emphasized that they will keep international bodies informed about ongoing health developments, as laboratory results decisively ruled out any immediate outbreak. Nonetheless, the Marburg virus poses a significant threat, with a fatality rate that averages around 50% for infected individuals and no established treatments or vaccines currently available, although research trials are underway.In balancing health concerns and the need for transparent communication, Tanzania appears committed to managing the situation while collaborating closely with global health authorities, underscoring the importance of vigilance and cooperation in addressing infectious diseases.
